Li Zeng

4.8k total citations · 2 hit papers
112 papers, 3.2k citations indexed

About

Li Zeng is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Li Zeng has authored 112 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 23 papers in Cancer Research and 22 papers in Cellular and Molecular Neuroscience. Recurrent topics in Li Zeng's work include Parkinson's Disease Mechanisms and Treatments (11 papers), MicroRNA in disease regulation (11 papers) and Neurogenesis and neuroplasticity mechanisms (10 papers). Li Zeng is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (11 papers), MicroRNA in disease regulation (11 papers) and Neurogenesis and neuroplasticity mechanisms (10 papers). Li Zeng collaborates with scholars based in China, Singapore and United States. Li Zeng's co-authors include Eng‐King Tan, Lifeng Qiu, Xisheng Weng, Baojie Li, Shuai Xiang, Ying Huang, Junjing Jia, Shixiong Yan, Tengfei Dou and Zonghui Jian and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Li Zeng

109 papers receiving 3.2k citations

Hit Papers

Spatially informed clustering, integration, and deco... 2021 2026 2022 2024 2023 2021 50 100 150 200

Peers

Li Zeng
Hui Ding China
Xia Qin China
Dong Woon Kim South Korea
Biao Chen China
Li Xu China
Jie Luo China
Hui Ding China
Li Zeng
Citations per year, relative to Li Zeng Li Zeng (= 1×) peers Hui Ding

Countries citing papers authored by Li Zeng

Since Specialization
Citations

This map shows the geographic impact of Li Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zeng more than expected).

Fields of papers citing papers by Li Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zeng. The network helps show where Li Zeng may publish in the future.

Co-authorship network of co-authors of Li Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Li Zeng. A scholar is included among the top collaborators of Li Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zeng. Li Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jingjie, Liang Bian, Mianxin Song, et al.. (2024). Clay minerals/sodium alginate/polyethylene hydrogel adsorbents control the selective adsorption and reduction of uranium: Experimental optimization and Monte Carlo simulation study. Journal of Hazardous Materials. 468. 133725–133725. 38 indexed citations
2.
Long, Yahui, Kok Siong Ang, Mengwei Li, et al.. (2023). Spatially informed clustering, integration, and deconvolution of spatial transcriptomics with GraphST. Nature Communications. 14(1). 1155–1155. 230 indexed citations breakdown →
4.
Jiang, Mei, Se‐Eun Jang, Dongrui Ma, et al.. (2022). The APP intracellular domain promotes LRRK2 expression to enable feed-forward neurodegenerative mechanisms in Parkinson’s disease. Science Signaling. 15(748). eabk3411–eabk3411. 8 indexed citations
5.
Zhou, Zhidong, Patrick Ho, Li Zeng, et al.. (2022). The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis. Cellular and Molecular Life Sciences. 79(12). 599–599. 35 indexed citations
6.
Dominguez, Jacqueline C., Yi Jayne Tan, Arlene R. Ng, et al.. (2021). Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis. Frontiers in Neurology. 12. 645913–645913. 9 indexed citations
7.
Zeng, Xiaoxia, Katarina Varnäs, Mei Jiang, et al.. (2020). Altered striatal dopamine levels in Parkinson’s disease VPS35 D620N mutant transgenic aged mice. Molecular Brain. 13(1). 164–164. 17 indexed citations
8.
Qiu, Lifeng, et al.. (2020). Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical Trials. Frontiers in Neuroscience. 14. 558532–558532. 18 indexed citations
9.
Wang, Yingjie, Wei Zhu, Li Zeng, et al.. (2018). Self-healing and injectable hybrid hydrogel for bone regeneration of femoral head necrosis and defect. Biochemical and Biophysical Research Communications. 508(1). 25–30. 26 indexed citations
10.
Wang, Jing, Xiaojie Chen, Wuling Liu, et al.. (2017). Characterization of oqxAB in Escherichia coli Isolates from Animals, Retail Meat, and Human Patients in Guangzhou, China. Frontiers in Microbiology. 8. 1982–1982. 20 indexed citations
11.
Ma, Dongrui, et al.. (2016). Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease. Stem Cell Research. 18. 48–50. 7 indexed citations
12.
Ren, Xiuhua, et al.. (2014). The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice. Leukemia Research. 38(9). 1085–1090. 12 indexed citations
13.
Li, Hong, et al.. (2014). Synthesis and biological evaluation of a novel class of coumarin derivatives. Bioorganic & Medicinal Chemistry Letters. 24(22). 5274–5278. 14 indexed citations
14.
Wong, Marcus Ho Yin, et al.. (2013). Characterization of Salmonella Food Isolates with Concurrent Resistance to Ceftriaxone and Ciprofloxacin. Foodborne Pathogens and Disease. 10(1). 42–46. 23 indexed citations
15.
Bichler, Zoë, et al.. (2013). Non-Motor and Motor Features in LRRK2 Transgenic Mice. PLoS ONE. 8(7). e70249–e70249. 49 indexed citations
16.
Shan, Wei, et al.. (2013). Screening of Differentially Expressed Genes Related to Bladder Cancer and Functional Analysis with DNA Microarray. Asian Pacific Journal of Cancer Prevention. 14(8). 4553–4557. 7 indexed citations
17.
Xie, Li, Wei Zhang, Rong Li, et al.. (2013). Ribosomal S6 Kinase 2 (RSK2) Maintains Genomic Stability by Activating the Atm/p53-Dependent DNA Damage Pathway. PLoS ONE. 8(9). e74334–e74334. 17 indexed citations
18.
Bi, Lanrong, Wei Bi, Li Zeng, et al.. (2006). Novel 2-substituted nitronyl nitroxides as free radical scavengers: Synthesis, biological evaluation and structure–activity relationship. Bioorganic & Medicinal Chemistry. 14(16). 5711–5720. 32 indexed citations
19.
Fasullo, Michael, Zheng Dong, Mingzeng Sun, & Li Zeng. (2005). Saccharomyces cerevisiae RAD53 (CHK2) but not CHK1 is required for double-strand break-initiated SCE and DNA damage-associated SCE after exposure to X rays and chemical agents. DNA repair. 4(11). 1240–1251. 10 indexed citations
20.
Zeng, Li, et al.. (2001). Evaluation of germ-cell kinetics in infertile patients with proliferating cell nuclear antigen proliferating index.. PubMed. 3(1). 63–6. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026